Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
acetylcholine, ARIA, binding, budget, cellular, certification, CMC, Cochin, conclusion, contrast, demand, DSMB, duly, exhibit, expiry, extended, factor, France, furnished, hereto, incorporated, insulin, interaction, isolated, Journal, located, location, macroeconomic, magnetic, marking, meaningful, medical, modification, Molecular, MRI, mTOR, neuroradiological, nicotinic, omitted, overactive, political, precise, receptor, Recessionary, recommended, renewed, resonance, schoen, signaling, swelling, thereunto, undersigned, vacant, Virtually, week
Removed:
al, allocation, applied, burden, caregiver, enhancing, foregoing, formulation, length, screened, target
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view